Martin K. Oehler

North Terrace
Adelaide, SA 5000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Proteomic analysis of malignant ascites and its impact on ovarian cancer spheroids.

Proteomic analysis of malignant ascites and its impact on ovarian cancer spheroids.

Journal: Clinical proteomics

Published: April 08, 2026

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion.

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion.

Journal: Journal of biomedical science

Published: March 05, 2026

Correction: Khan et al. Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels. Cancers 2023, 15, 4507.

Correction: Khan et al. Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels. Cancers 2023, 15, 4507.

Journal: Cancers

Published: February 13, 2026

Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review.

Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review.

Journal: Journal of proteome research

Published: January 28, 2026

Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology Registry.

Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology Registry.

Journal: JCO oncology practice

Published: January 14, 2026

Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study.

Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study.

Journal: Journal of proteome research

Published: December 23, 2025

Risk factors of ovarian cancer: a systematic review and meta-analysis of Mendelian randomiation studies.

Risk factors of ovarian cancer: a systematic review and meta-analysis of Mendelian randomiation studies.

Journal: Journal of public health (Oxford, England)

Published: September 19, 2025

Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.

Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.

Journal: International journal of molecular sciences

Published: July 07, 2025

Systemic Inflammation Response Index and primary cancer site predict futility of pelvic exenteration surgery for locally advanced and recurrent pelvic malignancy.

Systemic Inflammation Response Index and primary cancer site predict futility of pelvic exenteration surgery for locally advanced and recurrent pelvic malignancy.

Journal: The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland

Published: July 04, 2025

Identification of Proteins Associated with Ovarian Cancer Chemotherapy Resistance Using MALDI-MSI.

Identification of Proteins Associated with Ovarian Cancer Chemotherapy Resistance Using MALDI-MSI.

Journal: International journal of molecular sciences

Published: May 06, 2025

Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer.

Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer.

Journal: British journal of cancer

Published: February 18, 2025

Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian Cancer.

Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian Cancer.

Journal: Journal of cellular and molecular medicine

Published: January 29, 2025

Showing 1-12 of 133

Last Updated: 09/26/2026